figshare
Browse
Table_3.xls (5.5 kB)

Incremental cost-effectiveness ratios of including pre-adolescent boys in the childhood vaccination program compared to vaccination of pre-adolescent girls only.

Download (0 kB)
dataset
posted on 2014-03-20, 04:04 authored by Emily A. Burger, Stephen Sy, Mari Nygård, Ivar S. Kristiansen, Jane J. Kim
a

Assumes a cost per dose of $75, exclusive of the administration cost (≈$14 per dose).

b

Compared to no vaccination.

c

Compared to girls-only vaccination.

d

Includes female cervical, vulvar, vaginal, anal and oropharyngeal cancers,

e

Includes male anal, oropharyngeal and penile cancers,

f

Includes cervical, vulvar, vaginal, anal, oropharyngeal and penile cancers related to HPV-16, -18, and genital warts and recurrent respiratory papillomatosis related to HPV-6, -11.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    Computational biologyPopulation modelingInfectious disease modelingimmunologyVaccination and immunizationvaccinesCancer vaccinesepidemiologyEconomic epidemiologyInfectious disease epidemiologyhealth careHealth economicsInfectious diseasesSexually transmitted diseasesHuman papillomavirus infectionViral diseasesoncologyCancers and neoplasmsGenitourinary tract tumorsHead and neck tumorsCancer preventionurologyGenitourinary infectionswomen's healthObstetrics and gynecologyGynecologic cancersEconomicsEconomic analysisCost-effectiveness analysiscost-effectivenessratiospre-adolescentboysvaccinationcomparedgirls

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC